biote News

424B3: Prospectus

Nov 13 12:33 ET

10-Q: Q3 2024 Earnings Report

Nov 12 17:22 ET

8-K: Biote Reports Third Quarter 2024 Financial Results Continued Profitable Growth Vertical integration drives gross profit margin improvement Launch of proprietary clinical decision support software to strengthen competitive advantages

Nov 12 16:26 ET

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BANDERA PARTNERS LLC(7.5%),GREGORY BYLINSKY(7.5%), etc.

Nov 12 16:21 ET

SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.3%)

Nov 8 22:18 ET

SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.3%)

Oct 22 18:08 ET

4: Statement of changes in beneficial ownership of securities-Officer Peterson Robert Charles

Sep 11 15:36 ET

424B3: Prospectus

Aug 9 14:57 ET

424B3: Prospectus

Aug 9 14:57 ET

10-Q: Q2 2024 Earnings Report

Aug 9 13:57 ET

8-K: Biote Reports Second Quarter 2024 Financial Results Procedure revenue growth accelerates sequentially BioteRx roll-out on track with further expansion planned Management reiterates 2024 financial guidance

Aug 8 16:48 ET

4: Statement of changes in beneficial ownership of securities-Officer Peterson Robert Charles

Jul 10 16:35 ET

8-K: Current report

Jul 5 16:08 ET

8-K: Current report

Jul 3 16:12 ET

8-K: Current report

Jun 21 14:16 ET

4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director MORRIS DEBRA L

Jun 18 14:28 ET

8-K: Current report

May 24 07:31 ET

4: Statement of changes in beneficial ownership of securities-Director Jacoby Dana Lynn

May 23 16:13 ET

4: Statement of changes in beneficial ownership of securities-Director HEYER STEVEN J

May 23 16:13 ET

4: Statement of changes in beneficial ownership of securities-Director HEYER ANDREW R

May 23 16:12 ET